Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Children with non-alcoholic fatty liver disease need to be closely observed to help combat type 2 diabetes later in life.
This is according to the large randomized controlled START trial.
Highlights from HIV and hepatitis C research presented at the 2018 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston
Using Gilead Sciences’ Harvoni to treat hep C in certain people is more cost effective than waiting until their liver disease progresses.
The U.S. DHHS Guidelines for the Use of Antiretroviral Agents in HIV-1 Infected Adults and Adolescents has come nearly full circle...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.